| Use of a temporary prostatic stent after transurethral microwave thermotherapy reduced voiding symptoms and bother without exacerbating irritative symptoms. | |
| | |
MedLine Citation:
|
PMID: 18374395 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To evaluate the ability of a temporary prostatic stent (Spanner [Sp]) to manage voiding symptoms, irritative symptoms, and bother after transurethral microwave thermotherapy (TUMT) for prostatic obstruction. METHODS: Patients were randomized to the Sp (n = 100) or standard of care (SOC, n = 86) after TUMT with 3 to 10 days of routine catheterization. We evaluated International Prostate Symptom Score (IPSS) voiding subscore, IPSS irritative subscore, voiding diary data, and Benign Prostatic Hyperplasia Impact Index (BII) 7 to 10 days before TUMT and repeated them 1, 2, 4 (stent removal), 5, and 8 weeks after stent insertion. RESULTS: After 1 week of stent use, the Sp group experienced significantly greater improvements in the IPSS voiding subscore (Sp = -4.9 versus SOC = -2.3, P = 0.002) and individual voiding symptoms assessed by the IPSS (intermittency, weak stream, and straining) and voiding diary data (stream strength, and strain). After 2 weeks, the Sp group showed a trend toward greater improvements in IPSS voiding (P = 0.059) and irritative (P = 0.058) subscores and reported significantly less bother (BII, Sp = -2.1 versus SOC = -1.1, P = 0.033). After stent removal, the Sp group reported significantly greater improvements in the IPSS irritative subscore (5 weeks: Sp = -4.0 versus SOC = -2.7, P = 0.029; 8 weeks: Sp = -5.0 versus SOC = -4.0, P = 0.050), individual voiding (stream strength and dysuria), and irritative (frequency and urgency) symptoms and bother (5 weeks: Sp = -4.0 versus SOC = -2.3, P = 0.002; 8 weeks: Sp = -5.0 versus SOC = -3.1, P = 0.001). CONCLUSIONS: The Spanner, a temporary prostatic stent, improved voiding symptoms and bother without exacerbating irritative symptoms. Improvements in symptoms and bother were sustained after stent removal. |
| | |
Authors:
|
Martin K Dineen; Neal D Shore; Jeffrey H Lumerman; Mark J Saslawsky; Alberto P Corica |
Related Documents
:
|
18484875 - Planned nerve preservation to reduce positive surgical margins during robot-assisted la... 14764135 - Feasibility of open simple prostatectomy with early vascular control. 10643525 - Treatment of erectile dysfunction with external vacuum devices. 7508395 - Laser ablation of the prostate: experience with an ultrasound guided technique and a pr... 3498965 - Long-term intellectual dysfunction following coronary artery bypass graft surgery: a si... 16570675 - Topical miconazole nitrate ointment in the treatment of diaper dermatitis complicated b... |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial Date: 2008-03-28 |
Journal Detail:
|
Title: Urology Volume: 71 ISSN: 1527-9995 ISO Abbreviation: Urology Publication Date: 2008 May |
Date Detail:
|
Created Date: 2008-05-05 Completed Date: 2008-06-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0366151 Medline TA: Urology Country: United States |
Other Details:
|
Languages: eng Pagination: 873-7 Citation Subset: IM |
Affiliation:
|
Atlantic Urological Associates, Daytona Beach, Florida, USA. mdineen@auafl.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Humans Male Stents* Time Factors Transurethral Resection of Prostate / adverse effects* Urination Disorders / etiology, prevention & control* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The role of mechanoelectric feedback in vulnerability to electric shock.
Next Document: The effect of erectile function on the use of phosphodiesterase-5 inhibitors after radical prostatec...